Scantox Ballerup ApS: Financial statements 2014
CVR: 34724938
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Scantox Ballerup ApS (CVR 34724938) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 7,158,131 and a net result of DKK 89,675. Equity in the 2014 report amounted to DKK 214,878. The solvency ratio was 2.3%.
- Gross Profit
- DKK 7,158,131
- Profit/Loss
- DKK 89,675
- Equity
- DKK 214,878
- Total Assets
- DKK 9,387,982
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Scantox Ballerup ApS has published its interim report for the period October 23, 2012 – December 31, 2013.
As of March 19, 2014, Bent Højgaard is registered as director of Scantox Ballerup ApS.
About Scantox Ballerup ApS
Scantox Ballerup ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SOLURAL PHARMA ApS. The management consists of Helle Kirstein Erichsen. The board consists of Jeanet Løgsted Nielsen (chair) and Emil Staal Bergander. The company is owned by Scantox Denmark ApS. The company has 14 employees (2026). In 2025, the company reported a gross profit of DKK 13,349,106 and a net result of DKK -1,931,049 compared with DKK 255,010 the year before. Equity in the 2025 report amounted to DKK -1,539,321.